{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:05:13Z","timestamp":1793703913171,"version":"4.5.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-021-00338-z","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T06:04:25Z","timestamp":1623737065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control"],"prefix":"10.1038","volume":"6","author":[{"given":"Kirsten S.","family":"Vannice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Hills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Heffelfinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Hombach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. William","family":"Letson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Marfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Japanese encephalitis vaccination experts panel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayantha","family":"Liyanage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ike","family":"Ogbuanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyanit","family":"Tharmaphornpilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"338_CR1","doi-asserted-by":"crossref","unstructured":"Halstead, S. B., Hills, S. L. & Dubischar, K. in Plotkin\u2019s Vaccines (Seventh Edition) (Eds. Plotkin, S. A. et al.) 511\u2013548.e12 (Elsevier, 2018).","DOI":"10.1016\/B978-0-323-35761-6.00033-X"},{"key":"338_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.15585\/mmwr.mm6622a3","volume":"66","author":"JD Heffelfinger","year":"2017","unstructured":"Heffelfinger, J. D. et al. Japanese encephalitis surveillance and immunization \u2014 Asia and Western Pacific Regions, 2016. Mmwr. Morbidity Mortal. Wkly. Rep. 66, 579\u2013583 (2017).","journal-title":"Mmwr. Morbidity Mortal. Wkly. Rep."},{"key":"338_CR3","unstructured":"World Health Organization. Weekly epidemiological record Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire. WHO Weekly epidemiological record 90, 69\u201387 (2015)."},{"key":"338_CR4","first-page":"560","volume":"5","author":"RJ Schneider","year":"1974","unstructured":"Schneider, R. J., Firestone, M. H., Edelman, R., Chieowanich, P. & Pornpibul, R. Clinical sequelae after japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J. Trop. Med Public Health 5, 560\u2013568 (1974).","journal-title":"Southeast Asian J. Trop. Med Public Health"},{"key":"338_CR5","first-page":"445","volume":"26","author":"CS Kamala","year":"1989","unstructured":"Kamala, C. S., Rao, M. V., George, S. & Prasanna, N. Y. Japanese encephalitis in children in Bellary Karnataka. Indian Pediatr. 26, 445\u2013452 (1989).","journal-title":"Indian Pediatr."},{"key":"338_CR6","first-page":"171","volume":"267","author":"T Solomon","year":"2002","unstructured":"Solomon, T. & Vaughn, D. W. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr. Top. Microbiol. Immunol. 267, 171\u2013194 (2002).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"338_CR7","first-page":"549","volume":"25","author":"BV Huy","year":"1994","unstructured":"Huy, B. V., Tu, H. C., Luan, T. V. & Lindqvist, R. Early mental and neurological sequelae after Japanese B encephalitis. Southeast Asian J. Tropical Med. Public Health 25, 549\u2013553 (1994).","journal-title":"Southeast Asian J. Tropical Med. Public Health"},{"key":"338_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4269\/ajtmh.1958.7.481","volume":"7","author":"SJL Pieper","year":"1958","unstructured":"Pieper, S. J. L. & Kurland, L. T. Sequelae of Japanese B and mumps encephalitis. Am. J. Tropical Med. Hyg. 7, 481\u2013490 (1958).","journal-title":"Am. J. Tropical Med. Hyg."},{"key":"338_CR9","unstructured":"Japanese encephalitis vaccines: WHO Position Paper. WHO Wkly. Epidemiol. Rec. 325\u201340 (2006)."},{"key":"338_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJMp058263","volume":"355","author":"T Solomon","year":"2006","unstructured":"Solomon, T. Control of Japanese encephalitis \u2014 Within Our Grasp? N. Engl. J. Med. 355, 869\u2013871 (2006).","journal-title":"N. Engl. J. Med."},{"key":"338_CR11","first-page":"1","volume":"11","author":"Upreti Shyam Raj","year":"2017","unstructured":"Upreti Shyam Raj et al. Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal. PLOS Neglected Tropical Dis. 11, 1\u20139 (2017).","journal-title":"PLOS Neglected Tropical Dis."},{"key":"338_CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7883\/yoken.JJID.2008.333","volume":"61","author":"S Arai","year":"2008","unstructured":"Arai, S. et al. Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004. Jpn. J. Infect. Dis. 61, 333\u2013338 (2008).","journal-title":"Jpn. J. Infect. Dis."},{"key":"338_CR13","first-page":"135","volume":"3","author":"P Chen","year":"1992","unstructured":"Chen, P. et al. Observation of epidemiological effect of Japanese encephalitis (JE) live vaccine strain SA 14-14-2. Chin. J. Biologicals 3, 135\u2013137 (1992).","journal-title":"Chin. J. Biologicals"},{"key":"338_CR14","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","volume":"23","author":"J Hombach","year":"2005","unstructured":"Hombach, J., Solomon, T., Kurane, I., Jacobson, J. & Wood, D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004. Vaccine 23, 5205\u20135211 (2005).","journal-title":"Vaccine"},{"key":"338_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1056\/NEJM198809083191004","volume":"319","author":"CH Hoke","year":"1988","unstructured":"Hoke, C. H. et al. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med. 319, 608\u2013614 (1988).","journal-title":"N. Engl. J. Med."},{"key":"338_CR16","unstructured":"Prequalification of medicines by WHO. World Health Organization https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/prequalification-of-medicines-by-who (2013)."},{"key":"338_CR17","unstructured":"PATH. Navigating vaccine introduction: a guide for decision-makers\u2014Japanese encephalitis. https:\/\/www.path.org\/resources\/navigating-vaccine-introduction-a-guide-for-decision-makersjapanese-encephalitis\/ (2017)."},{"key":"338_CR18","unstructured":"World Health Organization & PATH. JE vaccines, health worker training materials. https:\/\/www.who.int\/immunization\/diseases\/japanese_encephalitis\/training-package\/en\/ (2016)."},{"key":"338_CR19","unstructured":"World Health Organization. Measuring effectiveness and impact of Japanese encephalitis vaccination. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255651\/WHO-IVB-16.03-eng.pdf (2016)."},{"key":"338_CR20","unstructured":"Regional Framework for Implementation of the Global Vaccine Action Plan in the Western Pacific. https:\/\/iris.wpro.who.int\/bitstream\/handle\/10665.1\/10921\/9789290617099_eng.pdf (2015)."},{"key":"338_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S1474-4422(10)70209-X","volume":"9","author":"MH Ooi","year":"2010","unstructured":"Ooi, M. H., Wong, S. C., Lewthwaite, P., Cardosa, M. J. & Solomon, T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 9, 1097\u2013105 (2010).","journal-title":"Lancet Neurol."},{"key":"338_CR22","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1128\/JCM.36.7.2030-2034.1998","volume":"36","author":"T Solomon","year":"1998","unstructured":"Solomon, T. et al. Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay. J. Clin. Microbiol. 36, 2030 (1998).","journal-title":"J. Clin. Microbiol."},{"key":"338_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1386-6532(99)00076-1","volume":"16","author":"AJ Cuzzubbo","year":"2000","unstructured":"Cuzzubbo, A. J. et al. Comparison of PanBio dengue Duo Igm and IgG capture ELISA and venture technologies dengue IgM and IgG dot blot. J. Clin. Virol. 16, 135\u2013144 (2000).","journal-title":"J. Clin. Virol."},{"key":"338_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1365-3156.2010.02537.x","volume":"15","author":"P Lewthwaite","year":"2010","unstructured":"Lewthwaite, P. et al. Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples. Tropical Med. Int. Health 15, 811\u2013818 (2010).","journal-title":"Tropical Med. Int. Health"},{"key":"338_CR25","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.ijid.2009.11.020","volume":"14","author":"A Khalakdina","year":"2010","unstructured":"Khalakdina, A. et al. Field evaluation of commercial Immunoglobulin M antibody capture ELISA diagnostic tests for the detection of Japanese encephalitis virus infection among encephalitis patients in Nepal. Int. J. Infect. Dis. 14, e79\u2013e84 (2010).","journal-title":"Int. J. Infect. Dis."},{"key":"338_CR26","doi-asserted-by":"publisher","first-page":"820","DOI":"10.4269\/ajtmh.15-0631","volume":"94","author":"BW Johnson","year":"2016","unstructured":"Johnson, B. W., Goodman, C. H., Jee, Y. & Featherstone, D. A. Differential diagnosis of japanese encephalitis virus infections with the inbios JE detect TM and DEN detect TM MAC-ELISA kits. Am. J. Tropical Med. Hyg. 94, 820\u2013828 (2016).","journal-title":"Am. J. Tropical Med. Hyg."},{"key":"338_CR27","doi-asserted-by":"publisher","unstructured":"Hills, S. et al. Persistence of IgM antibodies after vaccination with live attenuated Japanese encephalitis vaccine. Am. J. Tropical Med. Hygiene tpmd201132 https:\/\/doi.org\/10.4269\/ajtmh.20-1132 (2020).","DOI":"10.4269\/ajtmh.20-1132"},{"key":"338_CR28","doi-asserted-by":"publisher","first-page":"S324","DOI":"10.1093\/infdis\/jix077","volume":"216","author":"MN Mulders","year":"2017","unstructured":"Mulders, M. N. et al. Expansion of surveillance for vaccine-preventable diseases: building on the global polio laboratory network and the global measles and rubella laboratory network platforms. J. Infect. Dis. 216, S324\u2013S330 (2017).","journal-title":"J. Infect. Dis."},{"key":"338_CR29","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2471\/BLT.10.085233","volume":"89","author":"G Campbell","year":"2011","unstructured":"Campbell, G. et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull. World Health Organization 89, 766\u2013774 (2011).","journal-title":"Bull. World Health Organization"},{"key":"338_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-214","volume":"9","author":"S Hills","year":"2009","unstructured":"Hills, S. et al. Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance. BMC Infect. Dis. 9, 214 (2009).","journal-title":"BMC Infect. Dis."},{"key":"338_CR31","unstructured":"World Health Organization. Surveillance Standards for Vaccine-Preventable Diseases, Second Edition. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/275754\/9789241513920-eng.pdf (2018)."},{"key":"338_CR32","first-page":"276","volume":"35","author":"P Yoocharoan","year":"2009","unstructured":"Yoocharoan, P., A-neugoolpipat, A., Anantapreecha, S. & Tharmaphornpilas, P. Seroprevalence of immunity against Japanese encephalitis in Thai population. Dis. Control J. 35, 276\u2013284 (2009).","journal-title":"Dis. Control J."},{"key":"338_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4269\/ajtmh.2010.09-0125","volume":"82","author":"S Montgomery","year":"2010","unstructured":"Montgomery, S. et al. Hospital-based surveillance for Japanese encephalitis at four sites in Bangladesh, 2003\u20132005. Am. J. Tropical Med. Hyg. 82, 344\u2013349 (2010).","journal-title":"Am. J. Tropical Med. Hyg."},{"key":"338_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/infdis\/141.6.712","volume":"141","author":"UC Chaturvedi","year":"1980","unstructured":"Chaturvedi, U. C. et al. Transplacental infection with Japanese encephalitis virus. J. Infect. Dis. 141, 712\u2013715 (1980).","journal-title":"J. Infect. Dis."},{"key":"338_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3201\/eid2401.171297","volume":"24","author":"VCC Cheng","year":"2018","unstructured":"Cheng, V. C. C. et al. Japanese encephalitis virus transmitted via blood transfusion, Hong Kong, China. Emerg. Infect. Dis. J. 24, 49 (2018).","journal-title":"Emerg. Infect. Dis. J."},{"key":"338_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/ese.17.28.20221-en","volume":"17","author":"P Ravanini","year":"2012","unstructured":"Ravanini, P. et al. Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy. Eurosurveillance 17, 1\u20134 (2012).","journal-title":"Eurosurveillance"},{"key":"338_CR37","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMc1701600","volume":"376","author":"E Simon-Loriere","year":"2017","unstructured":"Simon-Loriere, E. et al. Autochthonous Japanese encephalitis with yellow fever coinfection in Africa. N. Engl. J. Med. 376, 1483\u20131485 (2017).","journal-title":"N. Engl. J. Med."},{"key":"338_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2020.00048","volume":"7","author":"ARS Oliveira","year":"2020","unstructured":"Oliveira, A. R. S. et al. Perspectives regarding the risk of introduction of the Japanese encephalitis virus (JEV) in the United States.Front. Vet. Sci. 7, 1\u20138 (2020).","journal-title":"Front. Vet. Sci."},{"key":"338_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/vbz.2008.0052","volume":"9","author":"RJ Nett","year":"2009","unstructured":"Nett, R. J., Campbell, G. L. & Reisen, W. K. Potential for the emergence of Japanese encephalitis virus in California. Vector-Borne Zoonotic Dis. 9, 511\u2013517 (2009).","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"338_CR40","unstructured":"SAGE Working Group on Japanese encephalitis vaccines. Background Paper on Japanese Encephalitis Vaccines. https:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/1_JE_Vaccine_Background_Paper.pdf (2014)."},{"key":"338_CR41","first-page":"38","volume":"20","author":"B Zhou","year":"1999","unstructured":"Zhou, B., Jia, L. & Xu, X. A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas. Chin Journal of Epidem 20, 38\u201341 (1999).","journal-title":"Chin Journal of Epidem"},{"key":"338_CR42","first-page":"183","volume":"14","author":"B Zhou","year":"2001","unstructured":"Zhou, B., Zhang, M., Chen, P., Jiang, X. & Zhang, L. An 11 Year Follow-up of Epidemiological Effect of Japanese Encephalitis Vaccine, Live (SA 14-14-2). Chin. J. Biologicals 14, 183\u2013185 (2001).","journal-title":"Chin. J. Biologicals"},{"key":"338_CR43","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.4161\/hv.29743","volume":"10","author":"DS Kim","year":"2014","unstructured":"Kim, D. S. et al. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea. Hum. Vaccines Immunother 10, 2656\u20132663 (2014).","journal-title":"Hum. Vaccines Immunother"},{"key":"338_CR44","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/INF.0000000000000276","volume":"33","author":"E Feroldi","year":"2014","unstructured":"Feroldi, E. et al. Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety. Pediatr. Infect. Dis. J. 33, 643\u2013649 (2014).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"338_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1086\/517358","volume":"177","author":"TF Tsai","year":"1998","unstructured":"Tsai, T. F. et al. Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine\u2014A comparison of 1- and 3-month immunization schedules. J. Infect. Dis. 177, 221\u2013223 (1998).","journal-title":"J. Infect. Dis."},{"key":"338_CR46","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.vaccine.2013.11.002","volume":"32","author":"JC Victor","year":"2014","unstructured":"Victor, J. C. et al. Corrigendum to \u201cComparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants\u201d [Vaccine 26 (2008) 2234\u20132241]. Vaccine 32, 306\u2013308 (2014).","journal-title":"Vaccine"},{"key":"338_CR47","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1016\/j.vaccine.2014.06.036","volume":"32","author":"PR Wijesinghe","year":"2014","unstructured":"Wijesinghe, P. R. et al. Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka. Vaccine 32, 4751\u20134757 (2014).","journal-title":"Vaccine"},{"key":"338_CR48","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1016\/j.vaccine.2014.09.012","volume":"32","author":"K Zaman","year":"2014","unstructured":"Zaman, K. et al. Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product. Vaccine 32, 6061\u20136066 (2014).","journal-title":"Vaccine"},{"key":"338_CR49","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","volume":"358","author":"MB Bista","year":"2001","unstructured":"Bista, M. B. et al. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 358, 791\u20135 (2001).","journal-title":"Lancet"},{"key":"338_CR50","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(05)67567-8","volume":"366","author":"H Ohrr","year":"2005","unstructured":"Ohrr, H. et al. Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. Lancet 366, 1375\u20138 (2005).","journal-title":"Lancet"},{"key":"338_CR51","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","volume":"25","author":"JB Tandan","year":"2007","unstructured":"Tandan, J. B. et al. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case\u2013control study in Nepalese children 5 years after immunization. Vaccine 25, 5041\u20135045 (2007).","journal-title":"Vaccine"},{"key":"338_CR52","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJMc0808664","volume":"360","author":"R Kumar","year":"2009","unstructured":"Kumar, R., Tripathi, P. & Rizvi, A. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N. Engl. J. Med. 360, 1465\u20131466 (2009).","journal-title":"N. Engl. J. Med."},{"key":"338_CR53","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","volume":"347","author":"S Hennessy","year":"1996","unstructured":"Hennessy, S. et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 347, 1583\u20131586 (1996).","journal-title":"Lancet"},{"key":"338_CR54","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jinf.2014.06.017","volume":"69","author":"MV Murhekar","year":"2014","unstructured":"Murhekar, M. V. et al. Low coverage and acceptable effectiveness of single dose of Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2013. J. Infect. 69, 517\u201320 (2014).","journal-title":"J. Infect."},{"key":"338_CR55","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/jmv.24556","volume":"88","author":"YK Gurav","year":"2016","unstructured":"Gurav, Y. K. et al. A large outbreak of Japanese encephalitis predominantly among adults in northern region of West Bengal, India. J. Med. Virol. 88, 2004\u20132011 (2016).","journal-title":"J. Med. Virol."},{"key":"338_CR56","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jiph.2018.04.011","volume":"11","author":"BV Tandale","year":"2018","unstructured":"Tandale, B. V. et al. Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: retrospective 1:4 matched case-control study. J. Infect. Public Health 11, 713\u2013719 (2018).","journal-title":"J. Infect. Public Health"},{"key":"338_CR57","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1080\/21645515.2017.1356496","volume":"13","author":"AS Ginsburg","year":"2017","unstructured":"Ginsburg, A. S., Meghani, A., Halstead, S. B. & Yaich, M. Use of the live attenuated Japanese encephalitis vaccine SA 14\u201314\u20132 in children: a review of safety and tolerability studies. Hum. Vaccines Immunother. 13, 2222\u20132231 (2017).","journal-title":"Hum. Vaccines Immunother."},{"key":"338_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-344","volume":"11","author":"N Jia","year":"2011","unstructured":"Jia, N. et al. Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports. BMC Infect. Dis. 11, 344 (2011).","journal-title":"BMC Infect. Dis."},{"key":"338_CR59","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.vaccine.2013.11.107","volume":"32","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005\u20132012. Vaccine 32, 1768\u20131773 (2014).","journal-title":"Vaccine"},{"key":"338_CR60","unstructured":"WHO | Global Advisory Committee on Vaccine Safety, report of meeting held on 11-12 December 2013. WHO Weekly Epidemiological Record on 14 February 2014 (2014)."},{"key":"338_CR61","unstructured":"World Health Organization, R. O. for S.-E. A. Prevention and Control of Japanese encephalitis (JE). (World Health Organization, 2015)."},{"key":"338_CR62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1473-3099(18)30650-9","volume":"19","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial. Lancet Infect. Dis. 19, 402\u2013409 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"338_CR63","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3201\/eid1705.101417","volume":"17","author":"Y-X Li","year":"2011","unstructured":"Li, Y.-X. et al. Japanese encephalitis, Tibet, China. Emerg. Infect. Dis. J. 17, 934 (2011).","journal-title":"Emerg. Infect. Dis. J."},{"key":"338_CR64","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3201\/eid1510.081641","volume":"15","author":"A Bhattachan","year":"2009","unstructured":"Bhattachan, A., Amatya, S., Sedai, T. R., Upreti, S. R. & Partridge, J. Japanese encephalitis in Hill and Mountain Districts. Nepal. Emerg. Infect. Dis. J. 15, 1691 (2009).","journal-title":"Nepal. Emerg. Infect. Dis. J."},{"key":"338_CR65","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4269\/ajtmh.2007.77.1146","volume":"77","author":"J Partridge","year":"2007","unstructured":"Partridge, J., Ghimire, P., Sedai, T., Bista, M. B. & Banerjee, M. Endemic Japanese encephalitis in the Kathmandu Valley, Nepal. Am. J. Trop. Med. Hyg. 77, 1146\u20131149 (2007).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"338_CR66","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/tmi.12104","volume":"18","author":"R Kumari","year":"2013","unstructured":"Kumari, R. et al. First indigenous transmission of Japanese encephalitis in urban areas of National Capital Territory of Delhi, India. Tropical Med. Int. Health 18, 743\u2013749 (2013).","journal-title":"Tropical Med. Int. Health"},{"key":"338_CR67","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","volume":"32","author":"HJ Larson","year":"2014","unstructured":"Larson, H. J., Jarrett, C., Eckersberger, E., Smith, D. M. D. & Paterson, P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007\u20132012. Vaccine 32, 2150\u20132159 (2014).","journal-title":"Vaccine"},{"key":"338_CR68","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/21645515.2018.1522468","volume":"15","author":"HJ Larson","year":"2019","unstructured":"Larson, H. J., Hartigan-Go, K. & de Figueiredo, A. Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness. Hum. Vaccines Immunother. 15, 625\u2013627 (2019).","journal-title":"Hum. Vaccines Immunother."},{"key":"338_CR69","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.4161\/21645515.2014.969618","volume":"10","author":"HJ Larson","year":"2014","unstructured":"Larson, H. J., Wilson, R., Hanley, S., Parys, A. & Paterson, P. Tracking the global spread of vaccine sentiments: The global response to Japan\u2019s suspension of its HPV vaccine recommendation. Hum. Vaccines Immunother. 10, 2543\u20132550 (2014).","journal-title":"Hum. Vaccines Immunother."},{"key":"338_CR70","unstructured":"Ten threats to global health in 2019. World Health Organization https:\/\/www.who.int\/news-room\/feature-stories\/ten-threats-to-global-health-in-2019."},{"key":"338_CR71","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijid.2016.02.904","volume":"45","author":"AK Singh","year":"2016","unstructured":"Singh, A. K., Joshi, J., Shewale, A. & Gupta, N. Lesson learned from investigating cluster adverse event following immunization in mass campaign of Japanese encephalitis vaccine in India. Int. J. Infect. Dis. 45, 425 (2016).","journal-title":"Int. J. Infect. Dis."},{"key":"338_CR72","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.vaccine.2008.02.042","volume":"26","author":"S Gatchalian","year":"2008","unstructured":"Gatchalian, S. et al. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants. Vaccine 26, 2234\u20132241 (2008).","journal-title":"Vaccine"},{"key":"338_CR73","unstructured":"Marfin, A. A. Antibody Persistence and the Immunologic Response to Booster Vaccination with Live Attenuated SA 14-14-2 Japanese Encephalitis Vaccine. in 68th Annual Meeting, American Society of Tropical Medicine and Hygiene (2019)."},{"key":"338_CR74","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/cid\/cis883","volume":"56","author":"EO Erra","year":"2013","unstructured":"Erra, E. O. et al. Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clin. Infect. Dis. 56, 267\u2013270 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"338_CR75","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.biologicals.2013.06.001","volume":"41","author":"DW Trent","year":"2013","unstructured":"Trent, D. W., Minor, P., Jivapaisarnpong, T. & Shin, J. WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21\u201323 February 2012. Biologicals 41, 450\u2013457 (2013).","journal-title":"Biologicals"},{"key":"338_CR76","doi-asserted-by":"publisher","first-page":"e1231","DOI":"10.1371\/journal.pntd.0001231","volume":"5","author":"M-H Li","year":"2011","unstructured":"Li, M.-H. et al. Genotype V Japanese encephalitis virus is emerging. PLoS Neglected Tropical Dis. 5, e1231 (2011).","journal-title":"PLoS Neglected Tropical Dis."},{"key":"338_CR77","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrneurol.2018.30","volume":"14","author":"L Turtle","year":"2018","unstructured":"Turtle, L. & Solomon, T. Japanese encephalitis \u2014 the prospects for new treatments. Nat. Rev. Neurol. 14, 298\u2013313 (2018).","journal-title":"Nat. Rev. Neurol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-021-00338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-021-00338-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-021-00338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T18:22:59Z","timestamp":1699122179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-021-00338-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["338"],"URL":"https:\/\/doi.org\/10.1038\/s41541-021-00338-z","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]},"assertion":[{"value":"27 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No conflicts of interest: G.W.L., J.M.H., J.H., S.H., L.M.S., K.V., A.A.M. T.S. is supported by the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (Grant No. IS-HPU-1112-10117), NIHR Global Health Research Group on Brain Infections (No. 17\/63\/110), and the European Union\u2019s Horizon 2020 research and innovation program ZikaPLAN (Preparedness Latin America Network), grant agreement No. 734584. A.D.T.B. is Editor in Chief of <i>npj Vaccines<\/i>.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}